Compare MYNZ & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MYNZ | ULY |
|---|---|---|
| Founded | 2021 | 2013 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4M | 4.8M |
| IPO Year | 2021 | 2023 |
| Metric | MYNZ | ULY |
|---|---|---|
| Price | $0.85 | $1.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $11.50 |
| AVG Volume (30 Days) | ★ 239.7K | 18.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $142,905,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.03 | $18.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.55 | $1.74 |
| 52 Week High | $5.34 | $17.99 |
| Indicator | MYNZ | ULY |
|---|---|---|
| Relative Strength Index (RSI) | 48.07 | 44.55 |
| Support Level | $0.57 | $1.81 |
| Resistance Level | $0.94 | $2.20 |
| Average True Range (ATR) | 0.09 | 0.13 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 69.44 | 39.47 |
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.